Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Alimera Sciences (ALIM)

Add to Watchlists
Create an Alert
6.12 -0.08  -1.29% NASDAQ Apr 23, 5:00PM BATS Real time Currency in USD
View Full Chart
ALIM Price Chart
View All Events

ALIM Events

Date Type Description
Feb 27 Misc Alimera Sciences, Inc. Q4 2013 Earnings Conference Call
Feb 27 Earnings Alimera Sciences, Inc. Q4 2013 Earnings Results. Estimate: -0.27.
Nov 11 Misc Alimera Sciences to Release Third Quarter Fiscal Year 2013 Financial Conference Call
Nov 11 Earnings Alimera Sciences to Release Third Quarter 2013 Results and Provide Update on Upcoming Fda Advisory Committee Meeting. Estimate: -0.30.
Aug 12 Misc Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Conference Call
Aug 12 Earnings Alimera Sciences to Release Second Quarter Fiscal Year 2013 Financial Results. Estimate: -0.17.
Jun 18 Misc AGM Event for Alimera Sciences Inc.
May 09 Earnings Alimera Sciences to Release First Quarter Fiscal Year 2013 Financial Results. Estimate: -0.20.
May 01 Misc Alimera Sciences to Release First Quarter Fiscal Year 2013 Financial Results
View All Performance Charts

ALIM Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alimera Sciences is up 104.7% over the last year vs S&P 500 Total Return up 22.59%, pSivida up 61.40%, and Affymetrix up 113.0%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ALIM

Did Alimera Sciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ALIM Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: United States
  • Headquarters State/Province: Georgia
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Alimera Sciences, Inc., is a biopharmaceutical company engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ALIM 6.12 -0.08 -1.29% 232.02M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.